These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 27311893

  • 1. Design, synthesis, and evaluation of water-soluble morpholino-decorated paclitaxel prodrugs with remarkably decreased toxicity.
    Feng S, Chen K, Wang C, Jiang X, Dong H, Gong Z, Liu K.
    Bioorg Med Chem Lett; 2016 Aug 01; 26(15):3598-602. PubMed ID: 27311893
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prodrug Strategies for Paclitaxel.
    Meng Z, Lv Q, Lu J, Yao H, Lv X, Jiang F, Lu A, Zhang G.
    Int J Mol Sci; 2016 May 23; 17(5):. PubMed ID: 27223283
    [Abstract] [Full Text] [Related]

  • 6. Fluorinated paclitaxel prodrugs for potentiated stability and chemotherapy.
    Jiang B, Hao D, Li C, Lu S, Pei Q, Xie Z.
    J Mater Chem B; 2021 Dec 15; 9(48):9971-9979. PubMed ID: 34871339
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and anti-cancer efficacy of rapid hydrolysed water-soluble paclitaxel pro-drugs.
    Ryu BY, Sohn JS, Hess M, Choi SK, Choi JK, Jo BW.
    J Biomater Sci Polym Ed; 2008 Dec 15; 19(3):311-24. PubMed ID: 18325233
    [Abstract] [Full Text] [Related]

  • 8. Water-soluble prodrugs of paclitaxel containing self-immolative disulfide linkers.
    Gund M, Khanna A, Dubash N, Damre A, Singh KS, Satyam A.
    Bioorg Med Chem Lett; 2015 Jan 01; 25(1):122-7. PubMed ID: 25466201
    [Abstract] [Full Text] [Related]

  • 9. Synthesis of paclitaxel-BGL conjugates.
    Nemoto H, Katagiri A, Kamiya M, Kawamura T, Matsushita T, Matsumura K, Itou T, Hattori H, Tamaki M, Ishizawa K, Miyamoto L, Abe S, Tsuchiya K.
    Bioorg Med Chem; 2012 Sep 15; 20(18):5559-67. PubMed ID: 22892212
    [Abstract] [Full Text] [Related]

  • 10. Paclitaxel esters of malic acid as prodrugs with improved water solubility.
    Damen EW, Wiegerinck PH, Braamer L, Sperling D, de Vos D, Scheeren HW.
    Bioorg Med Chem; 2000 Feb 15; 8(2):427-32. PubMed ID: 10722165
    [Abstract] [Full Text] [Related]

  • 11. Acetal-linked paclitaxel prodrug micellar nanoparticles as a versatile and potent platform for cancer therapy.
    Gu Y, Zhong Y, Meng F, Cheng R, Deng C, Zhong Z.
    Biomacromolecules; 2013 Aug 12; 14(8):2772-80. PubMed ID: 23777504
    [Abstract] [Full Text] [Related]

  • 12. Fine-Tuning the Linear Release Rate of Paclitaxel-Bearing Supramolecular Filament Hydrogels through Molecular Engineering.
    Chakroun RW, Wang F, Lin R, Wang Y, Su H, Pompa D, Cui H.
    ACS Nano; 2019 Jul 23; 13(7):7780-7790. PubMed ID: 31117370
    [Abstract] [Full Text] [Related]

  • 13. Irinotecan delivery by unimolecular micelles composed of reduction-responsive star-like polymeric prodrug with high drug loading for enhanced cancer therapy.
    Gao YE, Bai S, Shi X, Hou M, Ma X, Zhang T, Xiao B, Xue P, Kang Y, Xu Z.
    Colloids Surf B Biointerfaces; 2018 Oct 01; 170():488-496. PubMed ID: 29960949
    [Abstract] [Full Text] [Related]

  • 14. Nanoprodrug of retinoic acid-modified paclitaxel.
    Zhou Z, Yan J, Sun T, Wang X, Xie Z.
    Org Biomol Chem; 2017 Nov 22; 15(45):9611-9615. PubMed ID: 29106434
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and evaluation of water-soluble docetaxel prodrugs-docetaxel esters of malic acid.
    Du W, Hong L, Yao T, Yang X, He Q, Yang B, Hu Y.
    Bioorg Med Chem; 2007 Sep 15; 15(18):6323-30. PubMed ID: 17624790
    [Abstract] [Full Text] [Related]

  • 16. Synthesis of 2'-paclitaxel 2-deoxy-2-fluoro-glucopyranosyl carbonate for specific targeted delivery to cancer cells.
    Meng X, Lian X, Li X, Ya Q, Li T, Zhang Y, Yang Y, Zhang Y.
    Carbohydr Res; 2020 Jul 15; 493():108034. PubMed ID: 32485481
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and biological evaluation of paclitaxel and vorinostat co-prodrugs for overcoming drug resistance in cancer therapy in vitro.
    Liu S, Zhang K, Zhu Q, Shen Q, Zhang Q, Yu J, Chen Y, Lu W.
    Bioorg Med Chem; 2019 Apr 01; 27(7):1405-1413. PubMed ID: 30819618
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and biological evaluation of colchicine C-ring analogues tethered with aliphatic linkers suitable for prodrug derivatisation.
    Fournier-Dit-Chabert J, Vinader V, Santos AR, Redondo-Horcajo M, Dreneau A, Basak R, Cosentino L, Marston G, Abdel-Rahman H, Loadman PM, Shnyder SD, Díaz JF, Barasoain I, Falconer RA, Pors K.
    Bioorg Med Chem Lett; 2012 Dec 15; 22(24):7693-6. PubMed ID: 23103097
    [Abstract] [Full Text] [Related]

  • 19. Heparin-paclitaxel conjugates as drug delivery system: synthesis, self-assembly property, drug release, and antitumor activity.
    Wang Y, Xin D, Liu K, Zhu M, Xiang J.
    Bioconjug Chem; 2009 Dec 15; 20(12):2214-21. PubMed ID: 19950889
    [Abstract] [Full Text] [Related]

  • 20. Synthesis and preclinical characterization of a paclitaxel prodrug with improved antitumor activity and water solubility.
    Niethammer A, Gaedicke G, Lode HN, Wrasidlo W.
    Bioconjug Chem; 2001 Dec 15; 12(3):414-20. PubMed ID: 11353540
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.